Showing results (181-190 of 189) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
Journal for Immunotherapy of Cancer|September 22, 2022
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKIShruti Gupta, Clara Garcia-Carro, Jason M Prosek, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 6, 2015
Cross-Disciplinary Biomarkers Research: Lessons Learned by the CKD Biomarkers ConsortiumChi-Yuan Hsu, Shawn Ballard, Daniel Batlle, et al.
Kidney360|April 4, 2022
COVID-19 in Patients with Glomerular Disease: Follow-Up Results from the IRoc-GN International RegistryMeryl Waldman, Maria Jose Soler, Clara García-Carro, et al.
Kidney International|December 28, 2020
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplantNaoka Murakami, Patrick Mulvaney, Melissa Danesh, et al.
Mayo Clinic Proceedings|October 7, 2023
Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel ClassificationSanjeev Sethi, Laurence H Beck, Richard J Glassock, et al.
Kidney International|July 28, 2026
ISN International Expert Forum: Exploring the Nexus of Cardiovascular-Kidney-Metabolic (CKM) HealthRoberto Pecoits-Filho, Debasish Banerjee, Meg J Jardine, et al.
Kidney International|October 5, 2023
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classificationSanjeev Sethi, Laurence H Beck, Richard J Glassock, et al.
Journal for Immunotherapy of Cancer|October 9, 2021
Acute kidney injury in patients treated with immune checkpoint inhibitorsShruti Gupta, Samuel A P Short, Meghan E Sise, et al.
ACS Infectious Diseases|August 11, 2025
Collaborative Synthesis for Neglected Diseases through the Open Synthesis Network: Structure-Activity Relationships of Arylaminopyrazoles as Chagas Disease TreatmentsZigli Abdulai, Natasha Agbo, Jonathan I Anderson, et al.
Pageof 19